Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TMS CoTSE:4891 -5.00%31 3-Year ROIIC % is 13,208.30 as of Feb. 2025, which is 88% above its 10-year median of 7,037.88. GuruFocus rates TSE:4891 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,321 Biotechnology companies, TMS Co ranks better than 99.32% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
TMS Co's 3-Year ROIIC % for the quarter that ended in Feb. 2025 was 13,208.30%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for TMS Co's 3-Year ROIIC % or its related term are showing as below:
TSE:4891's 3-Year ROIIC % is ranked better than 99.32% of 1321
companies
in the Biotechnology industry
Industry Median: -4.85
vs TSE:4891: 13208.30
TMS Co (TSE:4891) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
TMS Co 3-Year ROIIC % Related Terms
TMS Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for TMS Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4891 vs VRTX, REGN, ALNY: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, TMS Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMS Co 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TMS Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where TMS Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
TMS Co (TSE:4891) has a 3-Year ROIIC % of 13,208.30 as of Feb. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on TMS Co and its competitors. This is 88% above median its historical median of 7,037.88. Over the past decade, TMS Co's 3-Year ROIIC % has ranged from 867.46 to 13,208.30. According to the industry distribution chart, TMS Co ranks #9 out of 1321 companies in the Biotechnology industry, placing it in the top 0.7%.
Is TMS Co's 3-Year ROIIC % too high?
TMS Co's current 3-Year ROIIC % of 13,208.30 is 88% above median its 10-year median of 7,037.88. Over the past 10 years, this metric has ranged from a low of 867.46 to a high of 13,208.30. Based on the distribution chart, TMS Co ranks #9 out of 1321 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, TMS Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TMS Co ranks #9 out of 1321 companies for 3-Year ROIIC %. This places TMS Co in the top 1% of its industry — outperforming the majority of peers. Historically, TMS Co's own 3-Year ROIIC % has ranged from 867.46 to 13,208.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on TMS Co and its competitors. TMS Co's current 3-Year ROIIC % is 13,208.30, which is 88% above median its own 10-year median of 7,037.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current 3-Year ROIIC % of 13,208.30. The current 3-Year ROIIC % is 13,208.30, which is 88% above median its 10-year median of 7,037.88. TMS Co's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For TMS Co (TSE:4891), the current 3-Year ROIIC % is 13,208.30 as of Feb. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
31GF Score
Get the complete analysis for TSE:4891
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4891 has been successfully added to your 
